Karen Brooks has over 22 years of clinical research experience. She is currently a Sr. Director Therapeutic Area Lead for Oncology and Early Phase Clinical Operations, in Pfizer’s Development Operations Group. She also serves on the Pfizer Initiative for Increasing Clinical Trial Diversity. Her prior roles included Director of Clinical Projects at Sanofi-Aventis where she also led an initiative to increase diversity in clinical trials. Her extensive years of experience have afforded her the opportunity to work with many investigators, study teams, recruitment and niche recruitment providers, as well as sponsor companies with the initiative to improve the inclusion of minorities and women in clinical trials. Ms. Brooks is currently pursuing her PhD in International HealthCare Research from Trident University focusing her research on African Americans/Blacks’ willingness to participate in clinical trials.